Essex Bio-Technology Limited announced that reference is made to the announcement of the Company dated 10 July 2020 in relation to the loan agreement entered into between the Company, Essex Bio-Investment Limited and Essex Bio-Pharmacy Limited as borrowers (collectively, the "Borrowers") and International Finance Corporation ("IFC") as lender, to which IFC agrees to lend, and the Borrowers agree to borrow a loan in the aggregate principal amount of USD 25,000,000 (equivalent to approximately HKD 195,750,000) (the " Announcement "). Unless otherwise stated herein, capitalized terms used in this announcement shall have the same meaning as defined in the Announcement. The board of directors of the Company (the "Board") announced that on 17 July 2023, the Borrowers have made voluntary repayment of the Loan in full ahead of the repayment schedule.